Galectin-3-deficient M(IFN-γ/LPS) macrophages proved to be less effective than wild-type (WT) counterparts in antilymphoma activity, but were comparable to WT macrophages in the promotion of lymphoma growth stimulated by apoptotic tumor cells. The gene discussed is LGALS3; the disease is neoplasm.